Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-24 @ 10:45 PM
NCT ID:
NCT02458235
Eligibility Criteria:
Inclusion Criteria:
* Patients age 0 - 29.9 years undergoing allogeneic peripheral blood stem cell transplant
* Patients with acute myelogenous leukemia (AML) or acute lymphoblastic leukemia (ALL)
* Patients with juvenile myelomonocytic leukemia (JMML)
* Patients with myelodysplastic syndrome (MDS)
Exclusion Criteria:
* Patients who have had a prior transplant.
* Patients with Fanconi anemia or other cancer-predisposition syndromes
* Patients with expected survival \<12 weeks
* Lansky score \<60%
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
29 Years
Study:
NCT02458235
Study Brief:
Protocol Section:
NCT02458235